The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1.
Open accessAbstract
The retinoblastoma gene product (pRB) participates in the regulation of the cell division cycle through complex formation with numerous cellular regulatory proteins including the potentially oncogenic cyclin D1. Extending the current view of the emerging functional interplay between pRB and D-type cyclins, we now report that cyclin D1 expression is positively regulated by pRB. Cyclin D1 mRNA and protein is specifically downregulated in cells expressing SV40 large T antigen, adenovirus E1A, and papillomavirus E7/E6 oncogene products and this effect requires intact RB-binding, CR2 domain of E1A. Exceptionally low expression of cyclin D1 is also seen in genetically RB-deficient cell lines, in which ectopically expressed wild-type pRB results in specific induction of this G1 cyclin. At the functional level, antibody-mediated cyclin D1 knockout experiments demonstrate that the cyclin D1 protein, normally required for G1 progression, is dispensable for passage through the cell cycle in cell lines whose pRB is inactivated through complex formation with T antigen, E1A, or E7 oncoproteins as well as in cells which have suffered loss-of-function mutations of the RB gene. The requirement for cyclin D1 function is not regained upon experimental elevation of cyclin D1 expression in cells with mutant RB, while reintroduction of wild-type RB into RB-deficient cells leads to restoration of the cyclin D1 checkpoint. These results strongly suggest that pRB serves as a major target of cyclin D1 whose cell cycle regulatory function becomes dispensable in cells lacking functional RB. Based on available data including this study, we propose a model for an autoregulatory feedback loop mechanism that regulates both the expression of the cyclin D1 gene and the activity of pRB, thereby contributing to a G1 phase checkpoint control in cycling mammalian cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The human papilloma virus-16 E7-oncoprotein is able to bind to the retinoblastoma gene product
Dyson, N., Howley, P. M., Münger, K., & Harlow, E. (1989) · Science · doi:10.1126/science.2537532 · Cited by 3,017 · cited 2×
“…target a series of key cellular regulators including product of the retinoblastoma tumor suppressor gene (pRB), pRB-related p107, cyclin A, cyclin E, and cd1¢2 kinase (DeCaprio et al., 1988; Whyte et al., 1988; Dyson et al., 1989; Giordano et al., 1989; Pines and Hunter, 1990; Faha et al., 1993).”
G 1 Events and Regulation of Cell Proliferation
Pardee, A. B. (1989) · Science · doi:10.1126/science.2683075 · Cited by 2,182
Sherr, C. J. (1993) · Cell · doi:10.1016/0092-8674(93)90636-5 · Cited by 1,960
Cyclin D1 is a nuclear protein required for cell cycle progression in G1
Baldin, V, Lukas, J., Marcote, M. J., Pagano, M., & Draetta, G. (1993) · Genes & Development · doi:10.1101/gad.7.5.812 · Cited by 1,614
Self-citationE2F: a Link Between the Rb Tumor Suppressor Protein and Viral Oncoproteins
Nevins, J. R. (1992) · Science · doi:10.1126/science.1411535 · Cited by 1,506
DeCaprio, J. A., Ludlow, J. W., Figge, J., Shew, J.-Y., Huang, C.-M., Lee, W.-H., Marsilio, E., Paucha, E., & Livingston, D. M. (1988) · Cell · doi:10.1016/0092-8674(88)90559-4 · Cited by 1,459
The E2F transcription factor is a cellular target for the RB protein
Chellappan, S. P., Hiebert, S., Mudryj, M., Horowitz, J. M., & Nevins, J. R. (1991) · Cell · doi:10.1016/0092-8674(91)90557-f · Cited by 1,412
Whyte, P., Buchkovich, K. J., Horowitz, J. M., Friend, S. H., Raybuck, M., Weinberg, R. A., & Harlow, E. (1988) · Nature · doi:10.1038/334124a0 · Cited by 1,403
Cyclin A is required at two points in the human cell cycle.
Pagano, M., Pepperkok, R., Verde, F., Ansorge, W., & Draetta, G. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05135.x · Cited by 1,403
ANIMAL CELL CYCLES AND THEIR CONTROL
Norbury, C., & Nurse, P. (1992) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.61.070192.002301 · Cited by 1,274
A novel cyclin encoded by a bcl1-linked candidate oncogene
Motokura, T., Bloom, T., Kim, H. G., Jüppner., H., Ruderman, J. V., Kronenberg, H. M., & Arnold, A. (1991) · Nature · doi:10.1038/350512a0 · Cited by 1,265
(1993) · Genes & Development · doi:10.1101/gad.7.3.331 · Cited by 1,264
Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle
Matsushime, H., Roussel, M. F., Ashmun, R. A., & Sherr, C. J. (1991) · Cell · doi:10.1016/0092-8674(91)90101-4 · Cited by 1,167
Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts.
Quelle, D. E., Ashmun, R. A., Shurtleff, S. A., Kato, J. Y., Bar-Sagi, D., Roussel, M. F., & Sherr, C. J. (1993) · Genes & Development · doi:10.1101/gad.7.8.1559 · Cited by 1,032
Xiong, Y., Zhang, H., & Beach, D. (1992) · Cell · doi:10.1016/0092-8674(92)90518-h · Cited by 1,021
Functional interactions of the retinoblastoma protein with mammalian D-type cyclins
Ewen, M. E., Sluss, H. K., Sherr, C. J., Matsushime, H., Kato, J.-Y., & Livingston, D. M. (1993) · Cell · doi:10.1016/0092-8674(93)90136-e · Cited by 1,010
Regulation of retinoblastoma protein functions by ectopic expression of human cyclins
Hinds, P. W., Mittnacht, S., Dulic, V., Arnold, A., Reed, S. I., & Weinberg, R. A. (1992) · Cell · doi:10.1016/0092-8674(92)90249-c · Cited by 995
The retinoblastoma protein is phosphorylated during specific phases of the cell cycle
Buchkovich, K., Duffy, L. A., & Harlow, E. (1989) · Cell · doi:10.1016/0092-8674(89)90508-4 · Cited by 995
Matsushime, H., Ewen, M. E., Strom, D. K., Kato, J.-Y., Hanks, S. K., Roussel, M. F., & Sherr, C. J. (1992) · Cell · doi:10.1016/0092-8674(92)90360-o · Cited by 897
The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines.
Scheffner, M., Münger, K., Byrne, J. C., & Howley, P. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.13.5523 · Cited by 849
Isolation of three novel human cyclins by rescue of G1 cyclin (cln) function in yeast
Lew, D. J., Dulić, V., & Reed, S. I. (1991) · Cell · doi:10.1016/0092-8674(91)90042-w · Cited by 833
Physical interaction of the retinoblastoma protein with human D cyclins
Dowdy, S. F., Hinds, P. W., Louie, K., Reed, S. I., Arnold, A., & Weinberg, R. A. (1993) · Cell · doi:10.1016/0092-8674(93)90137-f · Cited by 744
Human cyclin A is adenovirus E1A-associated protein p60 and behaves differently from cyclin B
Pines, J., & Hunter, T. (1990) · Nature · doi:10.1038/346760a0 · Cited by 715
Xiong, Y., Connolly, T., Futcher, B., & Beach, D. (1991) · Cell · doi:10.1016/0092-8674(91)90100-d · Cited by 685
A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F
Helin, K., Lees, J. A., Vidal, M., Dyson, N., Harlow, E., & Fattaey, A. (1992) · Cell · doi:10.1016/0092-8674(92)90107-n · Cited by 613
Inactivation of the Retinoblastoma Susceptibility Gene in Human Breast Cancers
Lee, E. Y.-H. P., To, H., Shew, J.-Y., Bookstein, R., Scully, P., & Lee, W.-H. (1988) · Science · doi:10.1126/science.3388033 · Cited by 581
Shirodkar, S., Ewen, M., DeCaprio, J. A., Morgan, J., Livingston, D. M., & Chittenden, T. (1992) · Cell · doi:10.1016/0092-8674(92)90214-w · Cited by 557
Horowitz, J. M., Park, S. H., Bogenmann, E., Cheng, J. C., Yandell, D. W., Kaye, F. J., Minna, J. D., Dryja, T. P., & Weinberg, R. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.7.2775 · Cited by 530
Kaelin, W. G., Pallas, D. C., DeCaprio, J. A., Kaye, F. J., & Livingston, D. M. (1991) · Cell · doi:10.1016/0092-8674(91)90236-r · Cited by 518
Ludlow, J. W., DeCaprio, J. A., Huang, C.-M., Lee, W.-H., Paucha, E., & Livingston, D. M. (1989) · Cell · doi:10.1016/0092-8674(89)90983-5 · Cited by 494
Ewen, M. E., Xing, Y., Lawrence, J. B., & Livingston, D. M. (1991) · Cell · doi:10.1016/0092-8674(91)90038-z · Cited by 444
Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner.
Lees, E., Faha, B., Dulic, V, Reed, S. I., & Harlow, E. (1992) · Genes & Development · doi:10.1101/gad.6.10.1874 · Cited by 438
Bandara, L. R., & La Thangue, N. B. (1991) · Nature · doi:10.1038/351494a0 · Cited by 418
Chittenden, T., Livingston, D. M., & Kaelin, W. G. (1991) · Cell · doi:10.1016/0092-8674(91)90559-h · Cited by 407
Structural Rearrangement of the Retinoblastoma Gene in Human Breast Carcinoma
T'Ang, A., Varley, J. M., Chakraborty, S., Murphree, A. L., & Fung, Y.-K. T. (1988) · Science · doi:10.1126/science.3175651 · Cited by 403
Harlow, E., Franza, B. R., & Schley, C. (1985) · Journal of Virology · doi:10.1128/jvi.55.3.533-546.1985 · Cited by 381
Lammie, G. A., Fantl, V., Smith, R., Schuuring, E., Brookes, S., Michalides, R. J. A. M., Dickson, C., Arnold, A., & Peters, G. B. (1991) · PubMed · Cited by 371
Cell cycle regulation of the E2F transcription factor involves an interaction with cyclin A
Mudryj, M., Devoto, S. H., Hiebert, S. W., Hunter, T., Pines, J., & Nevins, J. R. (1991) · Cell · doi:10.1016/0092-8674(91)90019-u · Cited by 356
The retinoblastoma protein is phosphorylated on multiple sites by human cdc2.
Lees, J. A., Buchkovich, K. J., Marshak, D. R., Anderson, C. W., & Harlow, E. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb05006.x · Cited by 337
Hu, Q. J., Dyson, N., & Harlow, E. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08221.x · Cited by 315
Musgrove, E. A., Hamilton, J. A., Lee, C. S., Sweeney, K. J., Watts, C. K., & Sutherland, R. L. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.6.3577 · Cited by 297
Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products.
Münger, K., Scheffner, M., Huibregtse, J. M., & Howley, P. M. (1992) · PubMed · Cited by 272
A 60 kd cdc2-associated polypeptide complexes with the E1A proteins in adenovirus-infected cells
Giordano, A., Whyte, P., Harlow, E., Franza, B. R., Beach, D., & Draetta, G. (1989) · Cell · doi:10.1016/0092-8674(89)90949-5 · Cited by 252
Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines.
Lukáš, J., Pagano, M., Stašková, Z., Draetta, G. F., & Bartek, J. (1994) · PubMed · Cited by 248
Self-citationInteractions of the p107 and Rb proteins with E2F during the cell proliferation response.
Schwarz, J. K., Devoto, S. H., Smith, E. J., Chellappan, S. P., Jakoi, L., & Nevins, J. R. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05742.x · Cited by 228
Association of cdk2 Kinase with the Transcription Factor E2F During S Phase
Pagano, M., Draetta, G., & Jansen-Dürr, P. (1992) · Science · doi:10.1126/science.1312258 · Cited by 226
Self-citationThe retinoblastoma protein and the regulation of cell cycling
Cobrinik, D., Dowdy, S. F., Hinds, P. W., Mittnacht, S., & Weinberg, R. A. (1992) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(92)90443-d · Cited by 201
Kaelin, W. G., Ewen, M. E., & Livingston, D. M. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.7.3761 · Cited by 197
Huang, S., Wang, N. P., Tseng, B. Y., Lee, W. H., & Lee, E. H. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08306.x · Cited by 196
Growth suppression of human breast cancer cells by the introduction of a wild-type p53 gene.
Casey, G., LO-HSUEH, M., Lopez, M. E., Vogelstein, B., & Stanbridge, E. J. (1991) · PubMed · Cited by 189
Motokura, T., & Arnold, A. (1993) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(93)90022-5 · Cited by 189
Stratton, M. R., Moss, S., Warren, W., Patterson, H., Clark, J. A., Fisher, C., Fletcher, C., Ball, A., Thomas, M., & Gusterson, B. A. (1990) · PubMed · Cited by 177
Simian virus 40 large T antigen: the puzzle, the pieces, and the emerging picture
Fanning, E. (1992) · Journal of Virology · doi:10.1128/jvi.66.3.1289-1293.1992 · Cited by 168
C-terminal truncation of the retinoblastoma gene product leads to functional inactivation.
Shew, J. Y., Lin, B. T., Chen, P. L., Tseng, B. Y., Yang-Feng, T. L., & Lee, W. H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.1.6 · Cited by 164
Molecular characterization of the retinoblastoma susceptibility gene
Goodrich, D. W., & Lee, W.-H. (1993) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(93)90021-4 · Cited by 159
Bartek, J. J., Bártková, J., Kyprianou, N., Lalani, E., Stašková, Z., Shearer, M., Chang, S. E., & Taylor‐Papadimitriou, J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.9.3520 · Cited by 150
Self-citationAdenovirus E1A targets key regulators of cell proliferation.
Dyson, N. J., & Harlow, E. (1992) · PubMed · Cited by 147
Fattaey, A., Harlow, E. E., & Helin, K. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.12.7267 · Cited by 145
A cellular protein that competes with SV40 T antigen for binding to the retinoblastoma gene product
Huang, S., Lee, W., & Lee, E. Y.-H. P. (1991) · Nature · doi:10.1038/350160a0 · Cited by 145
Motokura, T., Keyomarsi, K., Kronenberg, H. M., & Arnold, A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)88717-3 · Cited by 143
Doeberitz, M. V. K., Bauknecht, T., Bartsch, D., & Hausen, H. Z. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.4.1411 · Cited by 124
Imai, Y., Matsushima, Y., Sügimura, T., & Terada, M. (1991) · Journal of Virology · doi:10.1128/jvi.65.9.4966-4972.1991 · Cited by 93
The adenovirus E1A-associated kinase consists of cyclin E-p33cdk2 and cyclin A-p33cdk2
Faha, B., Harlow, E. E., & Lees, E. M. (1993) · Journal of Virology · doi:10.1128/jvi.67.5.2456-2465.1993 · Cited by 76
Molecular mechanism of retinoblastoma gene inactivation in retinoblastoma cell line Y79.
Lee, E. Y., Bookstein, R., Young, L. J., Lin, C. R., Rosenfeld, M. G., & Lee, W. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.16.6017 · Cited by 70
Dobbelstein, M., Ak, A., Dehde, S., et al. (1992) · PubMed · Cited by 64
Increased cyclin A and decreased cyclin D levels in adenovirus 5 E1A-transformed rodent cell lines.
Buchou, T., Kranenburg, O., van Dam, H., Roelen, D. L., ZANTEMA, A., Fl, H., & van der Eb, A. (1993) · PubMed · Cited by 48
Molecular pathology of the cell cycle in human cancer cells
rtek, J. R. I. B. A., aacute, Z. S. S. K., Draetta, G. F., & Lukáš, J. (1993) · Stem Cells · doi:10.1002/stem.5530110611 · Cited by 21
Diversity of human p53 mutants revealed by complex formation to SV40 T antigen
Bártek, J., Vojtěšek, B., & Lane, D. P. (1993) · European Journal of Cancer · doi:10.1016/0959-8049(93)90584-3 · Cited by 17
Cited by
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
Inhibitors of mammalian G1 cyclin-dependent kinases.
Sherr, C. J., & Roberts, J. M. (1995) · Genes & Development · doi:10.1101/gad.9.10.1149 · Cited by 3,243
G1 phase progression: Cycling on cue
Sherr, C. J. (1994) · Cell · doi:10.1016/0092-8674(94)90540-1 · Cited by 2,674
Cyclins and cancer II: Cyclin D and CDK inhibitors come of age
Hunter, T., & Pines, J. (1994) · Cell · doi:10.1016/0092-8674(94)90543-6 · Cited by 2,091
Metadata
- Authors
- Lukas, J., Müller, H., Bartkova, J., Spitkovsky, D., Kjerulff, A. A., Jansen-Dürr, P., Strauss, M., & Bartek, J.
- Venue
- The Journal of cell biology
- Publisher
- Rockefeller University Press
- Published
- 1994-05-01
- Volume
- 125
- Issue
- 3
- Pages
- 625-638
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- OpenAlex
- W2005941837
- Cited by
- 269
- References
- 68
- FWCI
- 14.34
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.